Subject(s)
Antibodies/therapeutic use , Antineoplastic Agents/therapeutic use , Apoptosis/drug effects , Caspases/metabolism , Drug Design , Enzyme Activators/therapeutic use , Immunoconjugates/therapeutic use , Neoplasms/drug therapy , Receptors, Antigen/drug effects , Animals , Antibodies/immunology , Antibodies/metabolism , Antigens, Neoplasm/immunology , Antigens, Neoplasm/metabolism , Antineoplastic Agents/immunology , Antineoplastic Agents/metabolism , Caspases/genetics , Enzyme Activation , Enzyme Activators/immunology , Enzyme Activators/metabolism , Humans , Immunoconjugates/immunology , Immunoconjugates/metabolism , Molecular Targeted Therapy , Neoplasms/immunology , Receptors, Antigen/immunology , Receptors, Antigen/metabolism , Signal Transduction/drug effectsABSTRACT
Melanisation is an important immune response in many invertebrates. Recent evidence also strongly implies that the melanisation (prophenoloxidase activating) cascade is intimately associated with the appearance of factors stimulating cellular defence by aiding phagocytosis and encapsulation reactions. However, some controversy exists in the field, and at least in flies and mosquitoes, the successful combat of some pathogens does not seem to be dependent on phenoloxidase activity. This may be because of redundancy among separate immune mechanisms, inappropriate testing, species differences or a combination thereof. Recently, by using RNA interference against phenoloxidase or in specific host-pathogen interactions where the pathogen prevents melanin production by the host, convincing data have confirmed the importance of this cascade in invertebrate innate immunity.
Subject(s)
Crustacea , Immunity/physiology , Melanins/biosynthesis , Monophenol Monooxygenase/metabolism , Animals , Bacterial Infections/immunology , Bacterial Infections/prevention & control , Enzyme Activators/immunology , Enzyme Activators/pharmacology , Enzyme Inhibitors/immunology , Enzyme Inhibitors/pharmacology , Immunity/drug effects , Insecta , Melanins/immunology , Monophenol Monooxygenase/immunology , Receptors, Pattern Recognition/immunology , Receptors, Pattern Recognition/metabolism , Serine Endopeptidases/immunology , Serine Endopeptidases/metabolism , Signal Transduction/immunologyABSTRACT
Chemerin is an attractant for cells that express the serpentine receptor CMKLR1, which include immature plasmacytoid dendritic cells (pDC) and macrophages. Chemerin circulates in the blood where it exhibits low biological activity, but upon proteolytic cleavage of its C terminus, it is converted to a potent chemoattractant. Enzymes that contribute to this conversion include host serine proteases of the coagulation, fibrinolytic, and inflammatory cascades, and it has been postulated that recruitment of pDC and macrophages by chemerin may serve to balance local tissue immune and inflammatory responses. In this work, we describe a potent, pathogen-derived proteolytic activity capable of chemerin activation. This activity is mediated by staphopain B (SspB), a cysteine protease secreted by Staphylococcus aureus. Chemerin activation is triggered by growth medium of clinical isolates of SspB-positive S. aureus, but not by that of a SspB(null) mutant. C-terminal processing by SspB generates a chemerin isoform identical with the active endogenous attractant isolated from human ascites fluid. Interestingly, SspB is a potent trigger of chemerin even in the presence of plasma inhibitors. SspB may help direct the recruitment of specialized host cells, including immunoregulatory pDC and/or macrophages, contributing to the ability of S. aureus to elicit and maintain a chronic inflammatory state.
Subject(s)
Chemokines/immunology , Cysteine Endopeptidases/immunology , Enzyme Activators/immunology , Staphylococcal Infections/immunology , Staphylococcus aureus/immunology , Animals , Ascites/immunology , Chemotaxis/immunology , Chronic Disease , Cysteine Endopeptidases/deficiency , Dendritic Cells/immunology , Humans , Intercellular Signaling Peptides and Proteins , Macrophages/immunology , Mice , Plasma/immunology , Receptors, Chemokine/immunology , Receptors, G-Protein-Coupled/immunology , Staphylococcus aureus/geneticsABSTRACT
There are two immune responses in vertebrates: humoral immunity is mediated by circulating antibodies, whereas cytotoxic T lymphocytes (CTL) confer cellular immunity. CTL lyse infected cells upon recognition of cell-surface MHC Class I molecules complexed with foreign peptides. The displayed peptides are produced in the cytosol by degradation of host proteins or proteins from intracellular pathogens that might be present. Proteasomes are cylindrical multisubunit proteases that generate many of the peptides eventually transferred to the cell surface for immune surveillance. In mammalian proteasomes, six active sites face a central chamber. As this chamber is sealed off from the enzyme's surface, there must be mechanisms to promote entry of substrates. Two protein complexes have been found to bind the ends of the proteasome and activate it. One of the activators is the 19 S regulatory complex of the 26 S proteasome; the other activator is '11 S REG' [Dubiel, Pratt, Ferrell and Rechsteiner (1992) J. Biol. Chem. 267, 22369-22377] or 'PA28' [Ma, Slaughter and DeMartino (1992) J. Biol. Chem. 267, 10515-10523]. During the past 7 years, our understanding of the structure of REG molecules has increased significantly, but much less is known about their biological functions. There are three REG subunits, namely alpha, beta and gamma. Recombinant REGalpha forms a ring-shaped heptamer of known crystal structure. 11 S REG is a heteroheptamer of alpha and beta subunits. REGgamma is also presumably a heptameric ring, and it is found in the nuclei of the nematode work Caenorhabditis elegans and higher organisms, where it may couple proteasomes to other nuclear components. REGalpha and REGbeta, which are abundant in vertebrate immune tissues, are located mostly in the cytoplasm. Synthesis of REG alpha and beta subunits is induced by interferon-gamma, and this has led to the prevalent hypothesis that REG alpha/beta hetero-oligomers play an important role in Class I antigen presentation. In the present review we focus on the structural properties of REG molecules and on the evidence that REGalpha/beta functions in the Class I immune response.
Subject(s)
Antigen Presentation , Cysteine Endopeptidases/immunology , Enzyme Activators/chemistry , Enzyme Activators/immunology , Histocompatibility Antigens Class I/metabolism , Multienzyme Complexes/immunology , Muscle Proteins , Proteins/chemistry , Proteins/immunology , Amino Acid Sequence , Animals , Catalytic Domain , Chromosome Mapping , Cysteine Endopeptidases/chemistry , Cysteine Endopeptidases/metabolism , Humans , Interferon-gamma/pharmacology , Models, Molecular , Molecular Sequence Data , Multienzyme Complexes/chemistry , Multienzyme Complexes/metabolism , Proteasome Endopeptidase Complex , Protein Conformation , Protein Structure, Quaternary , Proteins/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Substrate Specificity , Tissue DistributionABSTRACT
Dendritic cells (DC) are highly specialized professional antigen presenting cells which are pivotal for the initiation and control of the cytotoxic T cell response. Upon stimulation by cytokines, bacteria, or CD40L DC undergo a maturation process from an antigen-receptive state to a state of optimal stimulation of T cells. We investigated the composition of proteasomes of DC derived from human peripheral blood monocytes before and after stimulation by CD40L, LPS, or proinflammatory cytokines (TNF-alpha + IL-6 + IL-1beta). Immunoprecipitation of proteasomes and analysis on two-dimensional gels revealed that during maturation the inducible proteasome subunits LMP2, LMP7, and MECL-1 are up-regulated and that the neosynthesis of proteasomes is switched exclusively to the production of immunoproteasomes containing these subunits. The proteasome regulator PA28 is markedly up-regulated in mature DC and in addition a so - far unidentified 21-kDa protein co-precipitates with the proteasome in LPS - stimulated DC. These changes in proteasome composition may be functionally linked to special properties of DC like MHC class I up-regulation or cross-priming. Our findings imply that the spectrum of class I-bound peptides may change after DC maturation which could be relevant for the design of DC - based vaccines.
Subject(s)
Cysteine Endopeptidases/immunology , Dendritic Cells/immunology , Enzyme Activators/immunology , Multienzyme Complexes/immunology , Muscle Proteins , Proteins/immunology , Antigen Presentation/immunology , Cell Differentiation/immunology , Cells, Cultured , Cysteine Endopeptidases/genetics , Dendritic Cells/cytology , Gene Expression Regulation/immunology , Humans , Multienzyme Complexes/genetics , Proteasome Endopeptidase Complex , Proteins/genetics , Up-Regulation/immunologyABSTRACT
Uroguanylin (UGN) and guanylin (GN) are the endogenous intestinal ligands for guanylyl cyclase C (GC-C). We examined the circadian expression of UGN, GN, and GC-C in the jejunum, ileum, and proximal colon of young adult rats by Northern blot analyses. These assays revealed that UGN is more abundant in the proximal small intestine, whereas GN and GC-C are more abundant in the proximal colon. mRNA levels showed significant circadian variation for UGN (3- to 18-fold peak/trough difference), GN (2.1- to 2.8-fold peak/trough difference), and GC-C (3- to 5-fold peak/trough difference). The maximal abundance occurred in the dark period for all three mRNAs, although peak UGN and GN expression occurred later in the dark period in the jejunum relative to the ileum and colon. Immunoblot analyses using monospecific polyclonal antibodies against UGN and GN prohormones confirmed the regional and circadian variation detected by Northern assays. Thus the expression of these genes is regulated not only by histological position but also by circadian time.